Main > RHEUMATOLOGY > Rheumatoid Arthritis > Treatment > Co.: SE. S. Anakinra



Co.: SE. S. Anakinra's subsections
(*) CA Approval Date: ?
(*) USA Approval Date: 2001. 11.14
Company
IL-1 Inhibition
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 5
Patent>UpDate: 2017. 05.30.
TradeMark
TradeMark Web-Site

Co.: SE. S. Anakinra's products
This section has no products